Professor Caroline Moore specialises in the detection, surveillance and minimally invasive treatment of prostate cancer, using an MRI-led approach. She is committed to individualised prostate cancer assessment and treatment, combining imaging with shared decision making for men with localised prostate cancer.
Professor Moore was the first woman in the UK to be a Professor of Urology. She has been an honorary consultant urologist at University College Hospitals Trust since 2012, and now leads the UCLH team for prostate cancer diagnosis, active surveillance and focal therapy. She is Head of Urology at University College London. Her research interests include using patient reported outcomes to identify and disseminate best surgical practice; the use of MRI and different approaches to psychological support for men on active surveillance; decision making in localised prostate cancer; and the development of non-traditional follow up methods after prostate cancer diagnosis.
Professor Moore and the team have won numerous awards for their work, including the BMJ Research Paper of the Year in 2019 for PRECISE – their international study showing that MRI-targeted biopsy is more accurate and efficient than standard prostate biopsies. They have delivered the highest number of focal treatments for prostate cancer, and have recently published outcomes for over 1000 men having focal high intensity focussed ultrasound (HIFU) as a first treatment for prostate cancer. Professor Moore has personally treated over 800 men with a focal therapy approach, and mentors urologists in this technique in the UK and internationally. She led the START international working groups on the use of MRI to detect prostate cancer, which led to the PRECISION study, of which she was Chief Investigator. She is working with Professor Mark Emberton on an MRC funded study (Re-Imagine Prostate Cancer screening) using MRI to screen for prostate cancer.
